StonvexLoading…
StonvexStonvexStonvexCore line items from SM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.48B | $3.14B | $2.44B | $1.62B |
Operating Income | $-298.00M | $1.00B | $817.68M | $571.20M |
Net Income | $-335.00M | $648.00M | $539.02M | $201.66M |
EPS (Diluted) | $-1.68 | $5.64 | $4.69 | $3.34 |
Total Assets | $19.14B | $9.25B | $9.09B | $8.99B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $449.00M | $368.00M | $162.25M | $101.88M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 239.70M | 114.63M | 114.55M | 114.63M |